Trevi Therapeutics, Inc. (TRVI)
NASDAQ: TRVI · Real-Time Price · USD
2.752
-0.018 (-0.66%)
Nov 21, 2024, 1:49 PM EST - Market open

Trevi Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2016
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2016
Selling, General & Admin
11.6510.2410.079.4910.167.31
Upgrade
Research & Development
36.5723.6819.8322.9822.3319.34
Upgrade
Operating Expenses
48.2133.9229.9132.4832.4926.65
Upgrade
Operating Income
-48.21-33.92-29.91-32.48-32.49-26.65
Upgrade
Interest Expense
-0.01-0.39-1.16-1.2-0.46-
Upgrade
Interest & Investment Income
3.94.751.740.010.180.79
Upgrade
Other Non Operating Income (Expenses)
-0.020.470.14-0.29-0.01-0.22
Upgrade
EBT Excluding Unusual Items
-44.35-29.1-29.19-33.96-32.78-26.07
Upgrade
Pretax Income
-44.35-29.1-29.19-33.96-32.78-26.07
Upgrade
Income Tax Expense
-0.03-0.03-0.04-0.02-0.02-0.02
Upgrade
Net Income
-44.32-29.07-29.15-33.94-32.76-26.05
Upgrade
Preferred Dividends & Other Adjustments
-----0.7
Upgrade
Net Income to Common
-44.32-29.07-29.15-33.94-32.76-26.75
Upgrade
Shares Outstanding (Basic)
1009965231812
Upgrade
Shares Outstanding (Diluted)
1009965231812
Upgrade
Shares Change (YoY)
1.57%53.44%182.56%26.48%53.88%2581.79%
Upgrade
EPS (Basic)
-0.44-0.29-0.45-1.49-1.81-2.28
Upgrade
EPS (Diluted)
-0.44-0.29-0.45-1.49-1.81-2.28
Upgrade
Free Cash Flow
-35.12-31.85-28.33-28.95-29.03-23.1
Upgrade
Free Cash Flow Per Share
-0.35-0.32-0.44-1.27-1.61-1.97
Upgrade
EBITDA
-48.07-33.8-29.86-32.43-32.44-26.61
Upgrade
D&A For EBITDA
0.140.120.040.050.050.04
Upgrade
EBIT
-48.21-33.92-29.91-32.48-32.49-26.65
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.